Plato Investment Management Ltd Makes New Investment in Intuitive Surgical, Inc. $ISRG

Plato Investment Management Ltd purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 10,914 shares of the medical equipment provider’s stock, valued at approximately $4,315,000.

A number of other hedge funds also recently made changes to their positions in ISRG. Main Street Group LTD bought a new stake in Intuitive Surgical in the first quarter valued at about $30,000. Laurel Wealth Advisors LLC bought a new position in Intuitive Surgical during the fourth quarter worth about $31,000. Vermillion Wealth Management Inc. lifted its stake in Intuitive Surgical by 58.1% during the first quarter. Vermillion Wealth Management Inc. now owns 68 shares of the medical equipment provider’s stock worth $31,000 after purchasing an additional 25 shares during the period. Turning Point Benefit Group Inc. boosted its holdings in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Finally, Motiv8 Investments LLC acquired a new stake in Intuitive Surgical during the fourth quarter valued at approximately $34,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Amy L. Ladd sold 400 shares of Intuitive Surgical stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the director owned 251 shares in the company, valued at approximately $95,129. The trade was a 61.44% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares in the company, valued at approximately $2,016,280. This represents a 6.99% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 17,088 shares of company stock worth $6,941,913. 0.60% of the stock is owned by company insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $394.51 on Monday. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88. The company has a 50 day moving average of $391.45 and a 200-day moving average of $440.66. The firm has a market cap of $139.37 billion, a price-to-earnings ratio of 45.19, a PEG ratio of 2.85 and a beta of 1.47.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. The business had revenue of $2.89 billion for the quarter, compared to the consensus estimate of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.Intuitive Surgical’s revenue was up 18.4% compared to the same quarter last year. During the same period in the previous year, the business earned $1.81 EPS. On average, analysts forecast that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on the company. Truist Financial dropped their target price on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a report on Thursday, July 16th. TD Cowen lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Tuesday, July 28th. BTIG Research lowered their price target on Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research report on Friday, July 17th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a research note on Tuesday, July 28th. Finally, Raymond James Financial reissued an “outperform” rating and set a $483.00 price objective (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Twenty-two analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $508.68.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.